CirChem AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.77	13.65	11.93	16.58	9.78	14.57
Cash & Short-Term Investments	6.77	13.65	11.93	16.58	9.78	14.57
Cash Growth	-18.63%	14.41%	-28.07%	69.61%	-32.88%	-34.00%
Accounts Receivable	1.78	1.62	1.54	1.77	0	0.01
Other Receivables	0.82	0.73	0.4	0.1	0.58	0.69
Total Trade Receivables	2.6	2.35	1.94	1.87	0.58	0.69
Inventory	0.71	0.44	0.13	0.07	0	0.69
Other Current Assets	0.64	0.52	0.44	0.16	0.27	0.22
Total Current Assets	10.73	16.97	14.44	18.68	10.63	16.16
Net Property, Plant & Equipment	2.56	2.41	46.74	40.43	39.68	35.98
Total Assets	64.18	69.47	61.18	59.11	50.3	52.14
Accounts Payable	2.7	1.49	2.11	1.49	2.28	1.56
Accrued Expenses	2.53	2.14	1.73	1.59	3.73	1.74
Short-Term Debt	-	-	-	-	-	2
Other Current Liabilities	6.14	8.62	6.19	12	17.41	17.72
Total Current Liabilities	11.38	12.24	10.03	15.08	23.42	23.02
Other Long-Term Liabilities	13.31	12.9	5.47	8.92	1.75	2.75
Total Long-Term Liabilities	13.31	12.9	5.47	8.92	1.75	2.75
Total Liabilities	24.69	25.14	15.5	24.01	25.17	25.77
Common Stock	2.51	2.51	2.09	1.81	1.07	0.8
Additional Paid-in Capital	53.87	53.87	44.61	50.41	46.77	43.72
Retained Earnings	-16.89	-12.05	-1.02	-17.11	-22.72	-18.15
Shareholders' Equity	39.49	44.33	45.68	35.11	25.13	26.37
Total Liabilities & Equity	64.18	69.47	61.18	59.11	50.3	52.14
Total Debt	-	0	0	0	0	2
Net Cash (Debt)	6.77	13.65	11.93	16.58	9.78	12.57
Net Cash Growth	-18.63%	14.41%	-28.07%	69.61%	-22.19%	-37.33%
Net Cash Per Share	0.18	0.37	0.40	0.62	0.56	0.98
Book Value	39.49	44.33	45.68	35.11	25.13	26.37
Book Value Per Share	1.03	1.21	1.51	1.32	1.44	2.06
Tangible Book Value	39.49	44.33	45.68	35.11	25.13	26.37
Tangible Book Value Per Share	1.03	1.21	1.51	1.32	1.44	2.06